Volume 14, Number 3—March 2008
Research
Integrated Food Chain Surveillance System for Salmonella spp. in Mexico1
Table 3
Source | % Resistant† |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
AMP | CHL | CIP | CRO | GEN | KAN | NAL | STR | SU | SXT | TET | |
Ill humans (n = 392) | 25.5 | 23.4 | 0.0 | 14.5 | 11.7 | 11.2 | 24.6 | 61.1 | 49.7 | 24.3 | 41.2 |
Asymptomatic children (n = 373) | 7.8 | 8.4 | 0.0 | 1.4 | 2.2 | 0.5 | 8.6 | 45.9 | 35.4 | 8.0 | 26.1 |
Chicken‡ (n = 546) | 7.7 | 7.4 | 0.0 | 3.6 | 2.6 | 1.8 | 30.6 | 58.9 | 38.9 | 11.5 | 36.8 |
Swine‡ (n = 1,237) | 18.3 | 22.9 | 0.6 | 4.2 | 8.4 | 9.0 | 26.0 | 73.1 | 62.1 | 24.2 | 55.3 |
Cattle‡ (n = 767) | 11.9 | 14.1 | 0.0 | 1.2 | 6.6 | 7.2 | 20.8 | 71.6 | 53.1 | 19.2 | 48.8 |
*AMP, ampicillin; CHL, chloramphenicol; CIP, ciprofloxacin; CRO, ceftriaxone; GEN, gentamicin; KAN, kanamycin; NAL, nalidixic acid; STR, streptomycin; SU, sulfisoxazole; SXT, trimethoprim-sulfamethoxazole; TET, tetracycline.
†Includes resistant and intermediate.
‡Includes isolates from food-animal intestines and the corresponding retail meat.
1Presented in part at the International Association for Food Protection 93rd Annual Meeting, August 13–16, 2006, Calgary, Alberta, Canada.
Page created: July 07, 2010
Page updated: July 07, 2010
Page reviewed: July 07, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.